KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 53 filers reported holding KYMERA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,260,360 | +28.3% | 234,558 | +112.2% | 0.00% | +50.0% |
| Q2 2023 | $2,541,614 | -25.1% | 110,553 | -3.9% | 0.00% | -33.3% |
| Q1 2023 | $3,395,463 | +22.9% | 115,042 | +3.9% | 0.00% | +50.0% |
| Q4 2022 | $2,763,421 | -44.4% | 110,714 | -51.5% | 0.00% | -50.0% |
| Q3 2022 | $4,968,000 | +11.2% | 228,210 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $4,467,000 | -50.4% | 226,859 | +6.5% | 0.00% | -33.3% |
| Q1 2022 | $9,012,000 | -24.1% | 212,960 | +13.9% | 0.01% | -25.0% |
| Q4 2021 | $11,875,000 | +34.1% | 187,027 | +24.1% | 0.01% | +33.3% |
| Q3 2021 | $8,855,000 | +21.2% | 150,746 | +0.0% | 0.01% | +20.0% |
| Q2 2021 | $7,309,000 | +25.1% | 150,694 | +0.2% | 0.01% | +25.0% |
| Q1 2021 | $5,842,000 | -37.8% | 150,332 | -0.8% | 0.00% | -42.9% |
| Q4 2020 | $9,398,000 | +91.6% | 151,575 | -0.1% | 0.01% | +75.0% |
| Q3 2020 | $4,904,000 | – | 151,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |